In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...

Intraoperative floppy iris syndrome is associated with an increased rate of severe intraoperative complications and greater ...

A retrospective study showed that the gender of the ophthalmologist influenced the amount of communication with the patient, ...

The combined companies will operate under the name Kalaris Therapeutics, Inc. and expects to report initial data from part 1 ...

The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...

ZEISS VISULAS Combi is an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp ...

CEO Stephen McLeod, MD, outlines the American Academy of Ophthalmology's commitment to advocating for evidence-based, sustainable, and equitable reforms that prioritize public health and access to ...

The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms.

The May 4 event, themed around Star Wars, will feature the latest innovations, foster open discussions, and provide a ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The decision to discontinue the trials comes shortly after the announcement that COAST missed its primary endpoint.

The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss.